Antithrombotic Therapy After Burr Hole Evacuation of Chronic Subdural Hematoma: A Post Hoc Analysis of 2 Randomized Clinical Trials
- PMID: 40455427
- PMCID: PMC12131169
- DOI: 10.1001/jamaneurol.2025.1433
Antithrombotic Therapy After Burr Hole Evacuation of Chronic Subdural Hematoma: A Post Hoc Analysis of 2 Randomized Clinical Trials
Plain language summary
This study investigates outcomes in patients undergoing surgery for chronic subdural hematoma comparing those receiving vs not receiving antithrombotic therapy.
Conflict of interest statement
References
-
- Fornebo I, Sjåvik K, Alibeck M, et al. Role of antithrombotic therapy in the risk of hematoma recurrence and thromboembolism after chronic subdural hematoma evacuation: a population-based consecutive cohort study. Acta Neurochir (Wien). 2017;159(11):2045-2052. doi: 10.1007/s00701-017-3330-x - DOI - PMC - PubMed
-
- Hjortdal Grønhøj M, Jensen TS, Miscov R, et al. ; DACSUHS Group . Optimal drainage time after evacuation of chronic subdural haematoma (DRAIN TIME 2): a multicentre, randomised, multiarm and multistage non-inferiority trial in Denmark. Lancet Neurol. 2024;23(8):787-796. doi: 10.1016/S1474-4422(24)00175-3 - DOI - PubMed
LinkOut - more resources
Full Text Sources
